CUE - Cue Biopharma GAAP EPS of -$0.31 beats by $0.07 revenue of $0.07M misses by $0.37M November, 14 2022 05:35 PM Cue Biopharma Inc. Cue Biopharma press release ( NASDAQ: CUE ): Q3 GAAP EPS of -$0.31 beats by $0.07 . Revenue of $0.07M misses by $0.37M . For further details see: Cue Biopharma GAAP EPS of -$0.31 beats by $0.07, revenue of $0.07M misses by $0.37M